Citigroup
ONC

Citigroup’s BeOne Medicines Ltd ONC Stock Holding History

Citigroup’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.16M Sell
14,000
-6,000
-30% -$1.94M ﹤0.01% 2109
2025
Q4 		$6.08M Hold
20,000
– – ﹤0.01% 1879
2025
Q3 		$6.81M Buy
+20,000
New +$6.07M ﹤0.01% 1768
2025
Q1 		– Sell
-29,900
Closed -$5.52M – 6062
2024
Q4 		$5.52M Buy
+29,900
New +$6.11M ﹤0.01% 1856
2024
Q3 		– Sell
-15,000
Closed -$2.14M – 5828
2024
Q2 		$2.14M Buy
+15,000
New +$2.31M ﹤0.01% 2294

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citigroup's ONC Position: Q1 2026 in Review

Citigroup increased its BeOne Medicines Ltd (ONC) stake by 82% in Q1 2026, buying an estimated $1.49M and bringing the position to 10,188 shares worth $3.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

Citigroup first reported a position in ONC in Q1 2016 and has held it in 39 quarters since. The position peaked at $21.9M in Q3 2018. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Citigroup held 10,188 shares of BeOne Medicines Ltd worth $3.03M as of Q1 2026.
  • Citigroup bought 4,590 BeOne Medicines Ltd shares in Q1 2026, an estimated $1.49M.
  • BeOne Medicines Ltd made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2370 holding.
  • Citigroup first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 39 quarters since.
  • Citigroup's BeOne Medicines Ltd position peaked at $21.9M in Q3 2018.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.